Table of Contents Table of Contents
Previous Page  113 148 Next Page
Information
Show Menu
Previous Page 113 148 Next Page
Page Background

tumours of lowmalignant potential and low- and high-grade

papillary UC), flat lesions (carcinoma

in situ

[CIS]), and

invasive carcinoma. As in bladder tumours, nonurothelial

differentiation (i.e., histologic variants) confers an adverse

risk factor.

3.2.2.

Tumour node metastasis staging

The tumour, node, metastasis (TNM) classification is

shown in

Table 1 [18]

. The regional lymph nodes are the

hilar and retroperitoneal nodes, and for the mid and distal

ureter, the intrapelvine nodes. Laterality does not affect N

classification.

Renal pelvic pT3 subclassification may discriminate

between microscopic infiltration of the renal parenchyma

(pT3a) and macroscopic infiltration or invasion of peripelvic

adipose tissue (pT3b)

[16,19,20] .

pT3b UTUC has a higher

risk of disease recurrence after RNU

[16,19]

.

3.2.3.

Tumour grade

Until 2004, the 1973 World Health Organisation (WHO)

classification was used for tumour grading and distin-

guished grades G1

G3

[1,21]

. The 2004 WHO classification

considers histological data to distinguish between nonin-

vasive tumours: papillary urothelial neoplasia of low

malignant potential, and low- and high-grade carcinomas

(low grade versus high grade). The current guidelines are

based on the 2004 WHO classifications

[22]

.

3.3.

Diagnosis

3.3.1.

Symptoms

The diagnosis of UTUC may be incidental or related to the

evaluation of symptoms that are generally limited

[1]

. The

[(Fig._1)TD$FIG]

Fig. 1

Selection of patients with UTUC for hereditary screening during the first medical interview.

HNPCC = hereditary nonpolyposis colorectal carcinoma; UTUC = upper urinary tract urothelial carcinoma.

Table 1

TNM classification 2017 for upper tract urothelial

carcinoma

[18]

T

primary tumour

TX Primary tumour cannot be assessed

T0

No evidence of primary tumour

Ta Noninvasive papillary carcinoma

Tis Carcinoma

in situ

T1

Tumour invades subepithelial connective tissue

T2

Tumour invades muscularis

T3

Tumour invades beyond muscularis into peripelvic fat or renal

parenchyma (renal pelvis)

Tumour invades beyond muscularis into periureteric fat (ureter)

T4

Tumour invades adjacent organs or through the kidney into

perinephric fat

N

regional lymph nodes

NX Regional lymph nodes cannot be assessed

N0

No regional lymph node metastasis

N1

Metastasis in a single lymph node 2 cm in the greatest dimension

N2

Metastasis in a single lymph node

>

2 cm, or multiple lymph nodes

M

distant metastasis

M0 No distant metastasis

M1 Distant metastasis

TNM = tumour, node, metastasis (classi

fi

cation).

E U R O P E A N U R O L O GY 7 3 ( 2 0 18 ) 111

1 2 2

113